Work

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

Year: 2011

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e31822e2941

Authors: Maria Q. Baggstrom, Yingwei Qi, Marianna Koczywas, Athanassios Argiris, Elizabeth A. Johnson, Michael J. Millward, Sara C. Murphy, Charles Erlichman, Charles M. Rudin, Ramaswamy Govindan

Institutions: Washington University in St. Louis, Alvin J. Siteman Cancer Center, Mayo Clinic, City Of Hope National Medical Center, City of Hope, University of Pittsburgh, UPMC Hillman Cancer Center, Mayo Clinic in Florida, Sir Charles Gairdner Hospital, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Science Council, National Institutes of Health, National Cancer Institute

Awards: G12431752, G3873038914, Early Therapeutics Development with Phase II Emphasis, G599695825, Cancer Center Support Grant

OpenAlex ID: W1983706975

FWCI: 5.649

Cites: 15

Cited by: 161

Related to: 10